Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mark Rogalski"'
Autor:
Rachel Sanborn, Nashat Gabrail, Benedito Carneiro, Mark O'Hara, Rodolfo Bordoni, Michael Gordon, Danny Khalil, Ralph Hauke, Cherie Taglienti, Mark Rogalski, Rachel Styles, Diego Alvarado, Deena Maurer, Linda Crew, Tibor Keler, Michael Yellin
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02a9369d6e75b5b9cbad821994762030
https://doi.org/10.1136/jitc-2022-sitc2022.0596
https://doi.org/10.1136/jitc-2022-sitc2022.0596
Autor:
Danny N. Khalil, Tracey Rawls, Tibor Keler, Rachel E. Sanborn, Diego Alvarado, Lawrence J. Thomas, Laura Vitale, Maen Abdelrahim, Michael J. Yellin, Thomas U. Marron, Thomas Hawthorne, Nina Bhardwaj, Ralph J. Hauke, Mark H. O'Hara, Rodolfo Bordoni, Mark Rogalski, Nashat Y. Gabrail, Michael S. Gordon
Publikováno v:
Regular and young investigator award abstracts.
Background CDX-1140 is an agonist anti-CD40 mAb selected to optimize systemic exposure and hence tumor microenvironment (TME) ingress. CDX-1140 activity may be enhanced by combining with CDX-301 (recombinant Flt3L), a dendritic cell growth factor, or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45c4d5fd7e93436ea6f5ed40604681e0
https://doi.org/10.1136/jitc-2020-sitc2020.0405
https://doi.org/10.1136/jitc-2020-sitc2020.0405
Autor:
Neeraj Agarwal, Michael S. Gordon, Mark Rogalski, Bradley Alexander McGregor, Tibor Keler, Saby George, Thomas Hawthorne, Ronan Flippot, David I. Quinn, Toni K. Choueiri
Publikováno v:
Invest New Drugs
CDX-014 is an antibody-drug conjugate directed against TIM-1, a surface marker highly expressed in renal cell carcinoma (RCC) and ovarian carcinoma. This phase I, first-in-human trial was conducted to evaluate the safety and preliminary activity of C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f64696971fb94d0548b0dca1a627e13
https://europepmc.org/articles/PMC7578086/
https://europepmc.org/articles/PMC7578086/
Autor:
Nashat Y. Gabrail, Thomas Hawthorne, Nina Bhardwaj, Michael S. Gordon, Danny N. Khalil, Mark H. O'Hara, Michael J. Yellin, Rachel E. Sanborn, Tibor Keler, Richard Gedrich, Laura Vitale, Mark Rogalski, Tracey Rawls, Tianshu Li
Publikováno v:
Cancer Research. 79:LB-194
CDX-1140 is an agonist CD40 mAb intended to promote priming of CD8+ effector T cells through activation of dendritic cells (DC), enhance macrophage tumoricidal activity, and mediate direct killing of CD40-expressing tumor cells. CDX-1140 is a human I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27f8d3ceb08cfc3e957c643c374d17c7
https://doi.org/10.1158/1538-7445.am2019-lb-194
https://doi.org/10.1158/1538-7445.am2019-lb-194
Autor:
Wonjong Yu, Mark Rogalski, Xiaofeng Wang, Hongchao Wu, Prashanth Badrinarayanan, Michael R. Kessler
Publikováno v:
Macromolecular Materials and Engineering. 298:136-144
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e11b1c51e5433c7b2dce9bf9db9c1f8
https://doi.org/10.1002/mame.201100417
https://doi.org/10.1002/mame.201100417
Publikováno v:
ACS Applied Materials & Interfaces. 4:510-517
Fiber-reinforced composites are widely used in the design and fabrication of a variety of high performance aerospace components. The mismatch in coefficient of thermal expansion (CTE) between the high CTE polymer matrix and low CTE fiber reinforcemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::071e8da9e0a907d02a7baf2c27cc137c
https://doi.org/10.1021/am201165q
https://doi.org/10.1021/am201165q
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.